However, the EGFR mutation frequencies in East Asian lung adenocarcinoma were higher than previously reported in USA/Europe patients, whereas the overall frequency of KRAS mutations was much lower than in the West instead (D’Angelo et al., 2011; Smits et al., 2012; Kohno et al., 2015). This evidence concerns the gene EGFR and lung adenocarcinoma.